Neurontin Oral Capsule 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Neurontin: Oral capsule (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_7012.JPG
Neurontin 100mg Cap
Pfizer US Pharmaceuticals
Pill Identification: Neurontin 100 mg LOGO 

What is this Medicine?

GABAPENTIN (GA ba pen tin) is used to control partial seizures in adults with epilepsy. It is also used to treat certain types of nerve pain.

CVS Pharmacy Patient Statistics for Neurontin: Oral capsule(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Neurontin 100mg Capsule

NDC: 000710803
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Postherpetic Neuralgia, Partial Seizures

Sometimes used for but not FDA approved for the following conditions:
Pruritus, Menopause, Dysautonomia, Hot Flashes, Amyotrophic Lateral Sclerosis (ALS), Fibromyalgia, Multiple Sclerosis, Tremor, Singultus (hiccups), Spasticity, Diabetic Neuropathy, Nystagmus

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Neurontin 100mg Capsule
Drug Image file DrugItem_7012.JPG
Pfizer US Pharmaceuticals
Pill Identification: Neurontin 100 mg LOGO 
Shape: capsule
Color: white

Reported Side Effects for Neurontin 100mg Capsule

Choreoathetosis Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Tiredness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Thoughts Of Suicide Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
<8.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<7.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<7.0%*
Severity: MILD
Onset: EARLY
Withdrawal Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Tolerance Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Uncontrolled Movements Incidence:
>0.1%*
Severity: MODERATE
Onset: DELAYED
Dystonic Reaction Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Double Vision Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Conjunctivitis Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Decreased Memory Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Sugar Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Peripheral Vasodilation Incidence:
1.1%*
Severity: MODERATE
Onset: RAPID
Constipation Incidence:
1.4-4.0%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
>1.4%*
Severity: MILD
Onset: EARLY
Decreased Thinking Incidence:
1.7-2.7%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
>1.8%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Irritability Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Dysarthria Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Loss Of Memory Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Gas Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Lazy Eye Incidence:
3.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
3.0-30.0%*
Severity: MILD
Onset: EARLY
Incoordination Incidence:
3.0-13.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
3.0-8.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
3.0-11.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.3-6.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
4.0-10.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
4.0-8.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
4.5-27.0%*
Severity: MILD
Onset: EARLY
Hostility Incidence:
5.2-8.0%*
Severity: MODERATE
Onset: EARLY
Fast Eye Movements Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Neurontin 100mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Neurontin 100mg Capsule(Gabapentin)
Alcohol and Gabapentin(Gabapentin)
Avoid alcohol-containing drinks while taking Gabapentin. You may experience side effects like drowsiness, dizziness, headache, nausea, or fatigue if you drink alcohol-containing drinks while taking Gabapentin. Alcohol-containing drinks may also increase the actions of Gabapentin Enacarbil (Horizant) extended-release tablets, which may increase side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Neurontin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5